- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
2020 ASCO Update on CPIs in mUC: What Are the FDA Approved CPIs? Should the Checkpoint Therapy Be Moved Up Earlier? Is There a Benefit of CPIs in Adjuvant Setting?
By
Yale Cancer Center
FEATURING
Daniel Petrylak
By
Yale Cancer Center
FEATURING
Daniel Petrylak
344 views
June 12, 2020
Comments 0
Login to view comments.
Click here to Login
GU